48,830
edits
Difference between revisions of "Intraductal carcinoma of the prostate"
Jump to navigation
Jump to search
Intraductal carcinoma of the prostate (view source)
Revision as of 20:59, 6 April 2021
, 20:59, 6 April 2021no edit summary
| Line 11: | Line 11: | ||
| IHC = basal cells are present (CK34betaE12 +ve, p63 +ve) | | IHC = basal cells are present (CK34betaE12 +ve, p63 +ve) | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = +/-BRCA2 mutation | ||
| IF = | | IF = | ||
| Gross = | | Gross = | ||
| Line 17: | Line 17: | ||
| Site = [[prostate gland]] | | Site = [[prostate gland]] | ||
| Assdx = | | Assdx = | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = | | Clinicalhx = | ||
| Signs = | | Signs = | ||
| Line 27: | Line 27: | ||
| Prognosis = poor, strongly suggestive invasion if not present | | Prognosis = poor, strongly suggestive invasion if not present | ||
| Other = | | Other = | ||
| ClinDDx = | | ClinDDx = | ||
| Tx = | | Tx = | ||
}} | }} | ||
| Line 121: | Line 121: | ||
*CK34betaE12 +ve. | *CK34betaE12 +ve. | ||
*p63 +ve. | *p63 +ve. | ||
==Molecular== | |||
*+/-BRCA2 mutation. | |||
==See also== | ==See also== | ||